ISELIN, N.J., April 02, 2018 -- UBM Life Sciences Group’s Pharmaceutical Executive today opened nominations for Emerging Pharma Leaders, an awards program that for 10 years has recognized and honored up-and-coming professionals who are vital to the future of the pharmaceutical and biotech industry.
“It’s time again for us to ask, ‘Are you, or is your colleague, a leader in pharma?’” said Lisa Henderson, editor-in-chief of Pharmaceutical Executive. “Every year, nominees and winners find ways to inspire us. It's exciting to highlight their unique skills and qualities.”
Nominations of professionals employed by pharmaceutical or biotech companies will be judged by members of Pharmaceutical Executive’s editorial advisory board, and an Emerging Pharma Leaders alumnus.
“Emerging Pharma Leaders live and work across the world, but all share key qualities,” continued Henderson. “They show willingness to grow. They have the ability to listen. They learn from their mentors, and bring a special enthusiasm to lead their staff and share the load.”
Pharmaceutical Executive will accept nominations through June 30, 2018, reveal this year's winners through a special feature in its October issue, and celebrate their accomplishments with other industry leaders at a special, in-person event in November.
For more information, visit pharmexec.com/leaders2018.
About UBM Americas' Life Sciences Group
UBM Life Sciences is a US-based event, information, and marketing services business serving professional communities in human healthcare, veterinary medicine, and the pharmaceutical industry with an unmatched portfolio of in-person, print, and digital products. The business includes 4 trade shows, over 100 conferences, 30 publications, and over 100 digital products and websites. Reaching over 2 million life sciences professionals monthly, UBM Life Sciences enables the professional communities it serves to learn, connect, and conduct business. UBM Life Sciences is a business unit of UBM Americas, a division of UBM plc.
About UBM plc
UBM plc is the largest pure-play B2B Events organiser in the world. In an increasingly digital world, the value of connecting on a meaningful, human level has never been more important. At UBM, our deep knowledge and passion for the industry sectors we serve allow us to create valuable experiences where people can succeed. At our events people build relationships, close deals and grow their businesses.
Our 3,750+ people, based in more than 20 countries, serve more than 50 different industry sectors—from fashion to pharmaceutical ingredients. These global networks, skilled, passionate people and market-leading events provide exciting opportunities for business people to achieve their ambitions.
For more information, go to www.ubm.com; for UBM corporate news, follow us on Twitter at @UBM.
Media Contacts: UBM Americas - Life Sciences Group Amy Erdman Vice President, Marketing [email protected] (203) 523-7041


Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 



